Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL19664328

N.c1ccc(C2CCCC2)cc1

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ SLC18A3 Q16572 7/20 0.58
▸ SIGMAR1 Q99720 2/20 0.58
▸ CYP2D6 P10635 3/20 0.52
▸ TSHR P16473 2/20 0.52
▸ SMN1; SMN2 Q16637 2/20 0.52
▸ CYP1A2 P05177 1/20 0.52
▸ CYP2C9 P11712 1/20 0.52
▸ ALDH1A1 P00352 1/20 0.50
▸ APEX1 P27695 1/20 0.50
▸ BLM P54132 1/20 0.50
▸ CYP11B2 P19099 1/20 0.50
▸ TRPA1 O75762 1/20 0.48
▸ KMO O15229 1/20 0.48
▸ CYP2C19 P33261 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL3176297 0.97 SLC18A3 (0.61) SLC18A3SIGMAR1CYP2D6TSHRSMN1; SMN2
SCHEMBL42580 0.97 SLC18A3 (0.61) SLC18A3SIGMAR1CYP2D6TSHRSMN1; SMN2
SCHEMBL42833 0.94 SLC18A3 (0.63) SLC18A3SIGMAR1CYP2D6TSHRSMN1; SMN2
SCHEMBL11562787 0.94 SLC18A3 (0.63) SLC18A3SIGMAR1CYP2D6TSHRSMN1; SMN2
SCHEMBL790829 0.94 SLC18A3 (0.63) SLC18A3SIGMAR1CYP2D6TSHRSMN1; SMN2
Hydrochloric Acid SCHEMBL8036483 0.94 SLC18A3 (0.58) SLC18A3SIGMAR1CYP2D6TSHRSMN1; SMN2
SCHEMBL19262690 0.94 SLC18A3 (0.63) SLC18A3SIGMAR1CYP2D6TSHRSMN1; SMN2
Hydrogen Peroxide SCHEMBL2352938 0.94 SLC18A3 (0.58) SLC18A3SIGMAR1CYP2D6TSHRSMN1; SMN2
SCHEMBL19198566 0.94 SLC18A3 (0.63) SLC18A3SIGMAR1CYP2D6TSHRSMN1; SMN2
SCHEMBL447032 0.94 SLC18A3 (0.63) SLC18A3SIGMAR1CYP2D6TSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3055293-B1 DIARYLALKYLAMINE REV-ERB ANTAGONISTS AND THEIR USE AS MEDICAMENTS FOND ST ITALIANO TECNOLOGIA (IT) 2017-12-06 — — EP disclosed
Send feedback